Global Recommendations for Facial Rejuvenation Using a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable
Journal of Cosmetic Dermatology · 2026-01 · 25 (1)
DOI: 10.1111/jocd.70608 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 21.01.2026. Verfasst von Maurizio Cavallini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Operative Unit, Dermatology and Dermatosurgery, Centro Diagnostic Italiano Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Hyaluronic Acid, Durapatite, Rejuvenation, Skin Aging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Allergan Aesthetics, an AbbVie Company, Allergan Aesthetics.
Abstract (Originalsprache)
Background
The hybrid injectable HA‐CaHA contains a formulated matrix of crosslinked hyaluronic acid (HA) gel with embedded calcium hydroxyapatite (CaHA) microspheres to increase skin elasticity and hydration as well as promote neocollagenesis, respectively. Clinical practice recommendations for use of HA‐CaHA are limited.
Aims
The objective of this article was to provide global recommendations on safe and effective practices for injecting HA‐CaHA. Patient/Methods An expert panel consisting of eight international consultants was invited to discuss and provide best‐practice recommendations on HA ‐ CaHA patient selection, skin laxity assessment, injection techniques, touch‐up/retreatment practices, combination treatment protocols, and safety considerations.
Results
The expert panel recommended using HA‐CaHA for structural support and soft tissue repositioning in patients with skin laxity, sagginess, and mild to moderate loss of volume and contour. They also recommended defining injection entry points by referring to the line of ligaments and the zygomatic arch and keeping injections in the lateral and thus less mobile areas of the face. Experts advised using a cannula instead of a needle, retreating only if mild to moderate skin laxity recurs, and injecting in small volumes. Measures to minimize potential side effects, including injection site responses, were discussed.
Conclusions
Expert clinical recommendations affirm the safe and effective use of HA‐CaHA to improve soft tissue quality over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Operative Unit, Dermatology and Dermatosurgery, Centro Diagnostic Italiano Hospital, Milan, Italy.
- Dermatología Láser Cosmiatria Clinic, Rio de Janeiro, Brazil.
- Medicorium, Center for Dermatology and Aesthetics, Oberursel and Friedrichsdorf, Germany.
- Private Practice, Cracow, Poland.
- PHI Clinic, London, UK.
- Jouvence, Neuchâtel, Switzerland.
ORCID-Profile: Maurizio Cavallini, Fernando Urdiales Gálvez
Förderung
- Allergan Aesthetics, an AbbVie Company
- Allergan Aesthetics
Zitieren
APA
Cavallini, M., Braz, A., Greiner-Krüger, D., Lipko-Godlewska, S., Patel, T., Safa, M., Shotter, S., Gálvez, F. U., & Kerson, G. (2026). Global Recommendations for Facial Rejuvenation Using a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable. Journal of Cosmetic Dermatology, 25(1). https://doi.org/10.1111/jocd.70608
Vancouver
Cavallini M, Braz A, Greiner-Krüger D, Lipko-Godlewska S, Patel T, Safa M, et al. Global Recommendations for Facial Rejuvenation Using a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable. Journal of Cosmetic Dermatology. 2026;25(1). doi:10.1111/jocd.70608
BibTeX
@article{Cavallini2026,
author = {Cavallini, Maurizio and Braz, Andre and Greiner-Krüger, Daniela and Lipko-Godlewska, Sylwia and Patel, Tapan and Safa, Marva and Shotter, Sophie and Gálvez, Fernando Urdiales and Kerson, Graeme},
title = {Global Recommendations for Facial Rejuvenation Using a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {1},
doi = {10.1111/jocd.70608}
}
EUVIMED